Evidence map›Paper›PMID 18217555›Full record

ArticleEmerging infectious diseases2007

Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections.

Adam L Cohen, Carrie Shuler, Sigrid McAllister, Gregory E Fosheim, Michael G Brown, Debra Abercrombie, Karen Anderson, Linda K McDougal, Cherie Drenzek, Katie Arnold and 2 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Rapid eradication of vancomycin and methicillin-resistantFrontiers in bioengineering and biotechnology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Neurologic manifestations of chronic methamphetamine abuse.The Psychiatric clinics of North America · 2013
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adam L CohenRespiratory Diseases Brabch, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. alcohen1@cdc.gov
Carrie Shuler
Sigrid McAllister
Gregory E Fosheim
Michael G Brown
Debra Abercrombie
Karen Anderson
Linda K McDougal
Cherie Drenzek
Katie Arnold
Daniel Jernigan
Rachel Gorwitz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infections and methamphetamine use are emerging public health problems. We conducted a case-control investigation to determine risk factors for MRSA skin and soft tissue infections (SSTIs) in residents of a largely rural southeastern community in the United States. Case-patients were persons >12 years old who had culturable SSTIs; controls had no SSTIs. Of 119 SSTIs identified, 81 (68.1%) were caused by MRSA. Methamphetamine use was reported in 9.9% of case-patients and 1.8% of controls. After we adjusted for age, sex, and race, patients with MRSA SSTIs were more likely than controls to have recently used methamphetamine (odds ratio 5.10, 95% confidence interval 1.55-16.79). MRSA caused most SSTIs in this population. Transmission of MRSA may be occurring among methamphetamine users in this community.

Indexed as

MethamphetamineMethicillin ResistanceAdolescentAdultAgedAmphetamine-Related DisordersCase-Control StudiesCommunity-Acquired InfectionsDisease OutbreaksDrug Resistance, Multiple, BacterialElectrophoresis, Gel, Pulsed-FieldFemaleGeorgiaHumansMaleMiddle AgedMethamphetamine

Identifiers

PMID18217555
PMCPMC3375784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.